Home > News > S.A. firm licenses stent technology
December 15th, 2005
S.A. firm licenses stent technology
Abstract:
Advanced Bio Prosthetic Surfaces confirmed that it has licensed its stent-making technology for $10 million to Cordis Corp., a Johnson & Johnson company. Using a process known as nanosynthesis, Advanced Bio's researchers have improved the material used to make the stent, which leads to fewer impurities.
Source:
mysanantonio.com
Bookmark:
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013